WebBlake Borgeson. Co-founder and CTO at Recursion Pharmaceuticals. Location: Austin, Texas. Add to My Lists. Computational biologist and entrepreneur aiming with my career to bring >>1% of the level of computational resources and talent currently devoted to improving Google’s search engine to bear on biology and diseases. WebFeb 23, 2024 · Blake Borgeson owns about 7,594,057 units of Recursion Pharmaceuticals, Inc common stock. In the last 2 years at Recursion Pharmaceuticals, Inc, Blake Borgeson has sold an estimated value of $1 ...
Did you know?
WebApr 25, 2016 · Blake Borgeson, CTO of Recursion, added, “Rare diseases are the perfect targets for our unbiased, target-agnostic discovery platform as relatively little is known … WebBased on funding mandates. Blake Borgeson. Recursion Pharmaceuticals, prev UT Austin. Verified email at utexas.edu. Computational Biology Systems Biology.
WebMay 26, 2024 · Blake Borgeson, Recursion Pharmaceuticals, CTO & Co-Founder ©Robert Wright/LDV Vision Summit. Kaptur is the first magazine about the photo tech space. News, research and stats along with commentaries, industry reports and deep analysis written by industry experts. WebRecursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and …
WebView Blake Borgeson's email address (b*****@recurs***.com) and phone number. Blake works at Recursion Pharmaceuticals as Co-founder, Board Member. Blake is based out … WebJan 27, 2024 · Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) Director Blake Borgeson sold 8,885 shares of the stock in a transaction on Tuesday, January …
WebMar 25, 2024 · Blake Borgeson Sells 8,885 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock; Parker-Hannifin Co. (NYSE:PH) Shares Acquired by Ronald …
WebDec 3, 2024 · Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) Director Blake Borgeson sold 8,885 shares of the business’s stock in a transaction on Tuesday, November 29th. The shares were sold at an average price of $8.75, for a total transaction of $77,743.75. Following the completion of the transaction, the director now directly owns … sly williams basketballWebBlake Borgeson. Co-founder and CTO at Recursion Pharmaceuticals. Location: Austin, Texas. Add to My Lists. Computational biologist and entrepreneur aiming with my career … sly wet scrubbersWebApr 4, 2024 · RECURSION PHARMACEUTICALS, INC.: Borgeson Blake (Director) Sells 8,885 @ Avg Price: $7.40 (Form4) RECURSION PHARMACEUTICALS, INC.: Gibson Christopher (Director, Chief Executive Officer) (Form4 ... sly we flyWebThe Registered Agent on file for this company is C T Corporation System and is located at 1999 Bryan St., Ste. 900, Dallas, TX 75201-3136. The company has 8 contacts on record. The contacts are Blake Borgeson from Salt Lake City UT, Christopher Gibson from Salt Lake City UT, Dean Y Li from Salt Lake City UT, R Martin Chavez from Salt Lake City ... sly whistleWebBlake Borgeson MIRI + Recursion, AI + biology Berkeley, CA. Blake Borgeson -- United States. Blake Borgeson Intern at Lilly Bunn, Inc. … soldatholmenWebRecursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. ... The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake ... soldatenheim sonthofenWebJan 19, 2024 · Include Sam Altman (OpenAI), Jaan Tallinn (Skype), Blake Borgeson (Recursion Pharmaceuticals) Gameto (New York) 2024. $40 million. Include Future Ventures, Anne Wojcicki (23andMe), Bold Capital Partners, Lux Capital, Plum Alley, TA Ventures, Overwater Ventures, ARCH Venture Partners. Dioseve (Tokyo) 2024. JPY 400 … sol date sheet 2021